Slusher; Barbara S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Slusher; Barbara S..The latest application filed is for "glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy".
Company Profile
2.47.34
- Slusher; Barbara S. - Baltimore MD
- Slusher; Barbara S. - Kingsville MD
Patent Activity
| Patent | Date |
|---|---|
| Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy Grant 11,191,732 - Slusher , et al. December 7, 2 | 2021-12-07 |
| Glutaminase Inhibitor Discovery And Nanoparticle-enhanced Delivery For Cancer Therapy App 20200246274 - Kind Code | 2020-08-06 |
| Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy Grant 10,660,861 - Hanes , et al. | 2020-05-26 |
| Intranasal Administration Of Glutamate Carboxypeptidase (gcp-ii) Inhibitors App 20180338910 - SLUSHER; BARBARA S. ; et al. | 2018-11-29 |
| Methods For Bioanalysis Of 6-diazo-5-oxo-l-norleucine (don) And Other Glutamine Antagonists App 20180267067 - SLUSHER; BARBARA S. ; et al. | 2018-09-20 |
| Treatment of cognitive impairment in a subject with a neurological autoimmune disease Grant 9,737,552 - Kaplin , et al. August 22, 2 | 2017-08-22 |
| Glutaminase Inhibitor Discovery And Nanoparticle-enhanced Delivery For Cancer Therapy App 20170209387 - Hanes; Justin ; et al. | 2017-07-27 |
| Compounds and methods of use thereof for treating neurodegenerative disorders Grant 9,382,229 - Zack , et al. July 5, 2 | 2016-07-05 |
| High-throughput methods for determining pharmacological levels of plasma D-serine Grant 8,778,688 - Slusher , et al. July 15, 2 | 2014-07-15 |
| Quantitation of GCP activity in biological samples Grant 8,771,975 - Slusher , et al. July 8, 2 | 2014-07-08 |
| Compounds And Methods Of Use Thereof For Treating Neurodegenerative Disorders App 20140187540 - Zack; Donald J. ; et al. | 2014-07-03 |
| Treatment Of Cognitive Impairment In A Subject With A Neurological Autoimmune Disease App 20130344000 - Kaplin; Adam ; et al. | 2013-12-26 |
| Quantitation of GCP Activity in Biological Samples App 20130344525 - Slusher; Barbara S. ; et al. | 2013-12-26 |
| High-Throughput Methods for Determining Pharmacological Levels of Plasma D-Serine App 20130116293 - Slusher; Barbara S. ; et al. | 2013-05-09 |
| Thiolactones Grant 7,968,593 - Slusher , et al. June 28, 2 | 2011-06-28 |
| Thiolactones App 20100048667 - SLUSHER; Barbara S. ; et al. | 2010-02-25 |
| Thiolactones Grant 7,553,866 - Slusher , et al. June 30, 2 | 2009-06-30 |
| Methods of Administering Water-Soluble Prodrugs of Propofol App 20080214508 - Slusher; Barbara S. ; et al. | 2008-09-04 |
| Thiolactones App 20080004334 - Slusher; Barbara S. ; et al. | 2008-01-03 |
| Methods Of Administering Water-Soluble Prodrugs Of Propofol For Extended Sedation App 20070202158 - Slusher; Barbara S. ; et al. | 2007-08-30 |
| Naaladase inhibitors for treating retinal disorders and glaucoma Grant 7,220,780 - Slusher , et al. May 22, 2 | 2007-05-22 |
| Thiolactones App 20070037798 - Slusher; Barbara S. ; et al. | 2007-02-15 |
| Thiolactones Grant 7,125,907 - Slusher , et al. October 24, 2 | 2006-10-24 |
| Thiol-based NAALADase inhibitors App 20060135812 - Tsukamoto; Takashi ; et al. | 2006-06-22 |
| Thiol-based NAALADase inhibitors Grant 6,992,215 - Tsukamoto , et al. January 31, 2 | 2006-01-31 |
| Benzenedicarboxylic acid derivatives App 20050171065 - Jackson, Paul F. ; et al. | 2005-08-04 |
| Thiol-based NAALADase inhibitors App 20050085503 - Tsukamoto, Takashi ; et al. | 2005-04-21 |
| Naaladase inhibitors for treating huntington's disease App 20050080139 - Slusher, Barbara S. ; et al. | 2005-04-14 |
| Benzenedicarboxylic acid derivatives Grant 6,852,750 - Jackson , et al. February 8, 2 | 2005-02-08 |
| Thiolactones App 20050004203 - Slusher, Barbara S. ; et al. | 2005-01-06 |
| Thiol-based NAALADase inhibitors Grant 6,812,364 - Tsukamoto , et al. November 2, 2 | 2004-11-02 |
| Methods for treating certain diseases using naaladase inhibitors Grant 6,806,261 - Slusher , et al. October 19, 2 | 2004-10-19 |
| Naaladase inhibitors for treating opioid tolerance App 20040186081 - Slusher, Barbara S. ; et al. | 2004-09-23 |
| Thiol-based NAALADase inhibitors App 20030216468 - Tsukamoto, Takashi ; et al. | 2003-11-20 |
| Thiol-based NAALADase inhibitors Grant 6,586,623 - Tsukamoto , et al. July 1, 2 | 2003-07-01 |
| Thiol-based NAALADase inhibitors App 20030105088 - Tsukamoto, Takashi ; et al. | 2003-06-05 |
| NAALADase inhibitors useful as pharmaceutical compounds and compositions App 20030083374 - Jackson, Paul F. ; et al. | 2003-05-01 |
| Benzenedicarboxylic acid derivatives App 20030083505 - Jackson, Paul F. ; et al. | 2003-05-01 |
| Pharmaceutical compositions and methods of inhibiting angiogenesis using NAALADase inhibitors App 20030064912 - Slusher, Barbara S. ; et al. | 2003-04-03 |
| Naaladase inhibitors for treating retinal disorders and glaucoma App 20030036534 - Slusher, Barbara S. ; et al. | 2003-02-20 |
| Methods for treating certain diseases using naaladase inhibitors App 20030017965 - Slusher, Barbara S. ; et al. | 2003-01-23 |
| Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using NAALADase inhibitors App 20030013687 - Slusher, Barbara S. | 2003-01-16 |
| NAALADase inhibitors Grant 6,479,471 - Jackson , et al. November 12, 2 | 2002-11-12 |
| Methods of cancer treatment using naaladase inhibitors App 20020151503 - Slusher, Barbara S. ; et al. | 2002-10-17 |
| NAALADase inhibitors useful as pharmaceutical compounds and compositions Grant 6,458,775 - Jackson , et al. October 1, 2 | 2002-10-01 |
| Benzenedicarboxylic acid derivatives Grant 6,452,044 - Jackson , et al. September 17, 2 | 2002-09-17 |
| Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors Grant 6,413,948 - Slusher , et al. July 2, 2 | 2002-07-02 |
| Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors Grant 6,395,718 - Slusher , et al. May 28, 2 | 2002-05-28 |
| Methods of cancer treatment using NAALADase inhibitors Grant 6,372,726 - Slusher , et al. April 16, 2 | 2002-04-16 |
| Benzenedicarboxylic acid derivatives App 20020019430 - Jackson, Paul F. ; et al. | 2002-02-14 |
| Naaladase inhibitors for treating amyotrophic lateral sclerosis App 20020013295 - Slusher, Barbara S. ; et al. | 2002-01-31 |
| Hydroxamic acid derivatives App 20010044459 - Jackson, Paul F. ; et al. | 2001-11-22 |
| Phosphonic acid derivatives Grant 6,288,046 - Jackson , et al. September 11, 2 | 2001-09-11 |
| Hydroxamic acid derivatives Grant 6,271,245 - Jackson , et al. August 7, 2 | 2001-08-07 |
| Thio-substituted pentanedioic acid derivatives Grant 6,265,609 - Jackson , et al. July 24, 2 | 2001-07-24 |
| Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors Grant 6,228,888 - Slusher May 8, 2 | 2001-05-08 |
| Phosphinic acid derivatives Grant 6,121,252 - Jackson , et al. September 19, 2 | 2000-09-19 |
| Phosphinic alkanoic acid derivatives Grant 6,071,965 - Jackson , et al. June 6, 2 | 2000-06-06 |
| Phosphonic acid derivatives Grant 6,054,444 - Jackson , et al. April 25, 2 | 2000-04-25 |
| NAALADase inhibitors Grant 6,046,180 - Jackson , et al. April 4, 2 | 2000-04-04 |
| Certain dioic acid derivatives useful as NAALADase inhibitors Grant 6,025,344 - Jackson , et al. February 15, 2 | 2000-02-15 |
| Inhibitors of NAALADase enzyme activity Grant 6,025,345 - Jackson , et al. February 15, 2 | 2000-02-15 |
| Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors Grant 6,017,903 - Slusher , et al. January 25, 2 | 2000-01-25 |
| Methods of cancer treatment using naaladase inhibitors Grant 6,011,021 - Slusher , et al. January 4, 2 | 2000-01-04 |
| Treatment of global and focal ischemia using naaladase inhibitors Grant 6,004,946 - Slusher , et al. December 21, 1 | 1999-12-21 |
| Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia Grant 5,981,209 - Slusher , et al. November 9, 1 | 1999-11-09 |
| Naaladase inhibitors Grant 5,968,915 - Jackson , et al. October 19, 1 | 1999-10-19 |
| Hydroxamic acid derivatives Grant 5,962,521 - Jackson , et al. October 5, 1 | 1999-10-05 |
| Certain sulfoxide and sulfone derivatives Grant 5,902,817 - Jackson , et al. May 11, 1 | 1999-05-11 |
| Naaladase inhibitors Grant 5,880,112 - Jackson , et al. March 9, 1 | 1999-03-09 |
| Phosphoramidate derivatives Grant 5,863,536 - Jackson , et al. January 26, 1 | 1999-01-26 |
| Treatment of global and focal ischemia using naaladase inhibitors Grant 5,824,662 - Slusher , et al. October 20, 1 | 1998-10-20 |
| Methods of cancer treatment using naaladase inhibitors Grant 5,804,602 - Slusher , et al. September 8, 1 | 1998-09-08 |
| Inhibitors of NAALADase enzyme activity Grant 5,795,877 - Jackson , et al. August 18, 1 | 1998-08-18 |
| Certain phosphonomethyl-pentanedioic acid derivatives thereof Grant 5,672,592 - Jackson , et al. September 30, 1 | 1997-09-30 |
Company Registrations
| SEC | 0001206357 | SLUSHER BARBARA S |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 